Diseases of the Pituitary

Overview

Journal Neurosurg Clin N Am

Specialty Neurosurgery

Date 1994 Jan 1

PMID 8124095

Citations 4

Authors

S L Asa

Affiliations

Soon will be listed here.

Abstract

This article reviews current understanding of the pathology and pathogenesis of pituitary diseases. It emphasizes the importance of morphologic analysis in the diagnostic sphere. The investigation of structure-function correlations in pituitary adenomas combined with a greater understanding of the molecular basis of disease will lead to new discoveries and elucidate the factors underlying pituitary tumorigenesis.

Citing Articles

The role of genetic and epigenetic changes in pituitary tumorigenesis.

Fukuoka H, Takahashi Y Neurol Med Chir (Tokyo). 2014; 54(12):943-57.

PMID: 25446387 PMC: 4533359. DOI: 10.2176/nmc.ra.2014-0184.

Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity.

Tritos N, Eppakayala S, Swearingen B, Hedley-Whyte E, Miller K, Nachtigall L Pituitary. 2012; 16(3):287-93.

PMID: 22869255 DOI: 10.1007/s11102-012-0419-3.

Study of the telomerase hTERT fraction, PCNA and CD34 expression on pituitary adenomas. Association with clinical and demographic characteristics.

Ortiz-Plata A, Tena Suck M, Lopez-Gomez M, Heras A, Sanchez Garcia A J Neurooncol. 2007; 84(2):159-66.

PMID: 17361328 DOI: 10.1007/s11060-007-9365-8.

Prognostic indicators in pituitary tumors.

Suhardja A, Kovacs K, Greenberg O, Scheithauer B, Lloyd R Endocr Pathol. 2005; 16(1):1-9.

PMID: 16000840 DOI: 10.1385/ep:16:1:001.